207 related articles for article (PubMed ID: 9201147)
1. Successful treatment of infantile hemangiomas with interferon-alpha-2b.
Chang E; Boyd A; Nelson CC; Crowley D; Law T; Keough KM; Folkman J; Ezekowitz RA; Castle VP
J Pediatr Hematol Oncol; 1997; 19(3):237-44. PubMed ID: 9201147
[TBL] [Abstract][Full Text] [Related]
2. [Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas].
Dosquet C; Coudert MC; Wassef M; Enjolras O; Drouet L
Ann Dermatol Venereol; 1998 May; 125(5):313-6. PubMed ID: 9747277
[TBL] [Abstract][Full Text] [Related]
3. Treatment of massive or life-threatening hemangiomas with recombinant alpha(2a)-interferon.
Bauman NM; Burke DK; Smith RJ
Otolaryngol Head Neck Surg; 1997 Jul; 117(1):99-110. PubMed ID: 9230332
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.
Ezekowitz RA; Mulliken JB; Folkman J
N Engl J Med; 1992 May; 326(22):1456-63. PubMed ID: 1489383
[TBL] [Abstract][Full Text] [Related]
5. [Severe hemangiomas treated with interferon alpha-2b: seven cases].
Léauté-Labrèze C; Labbé L; Grenier N; Berge J; Vergnes P; Taïeb A
Ann Dermatol Venereol; 1998 Mar; 125(3):174-8. PubMed ID: 9747242
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangiomas in childhood.
Hastings MM; Milot J; Barsoum-Homsy M; Hershon L; Dubois J; Leclerc JM
J AAPOS; 1997 Dec; 1(4):226-30. PubMed ID: 10532768
[TBL] [Abstract][Full Text] [Related]
7. Treatment of a massive orbital-capillary hemangioma with interferon alfa-2b: short-term results.
Loughnan MS; Elder J; Kemp A
Arch Ophthalmol; 1992 Oct; 110(10):1366-7. PubMed ID: 1417530
[No Abstract] [Full Text] [Related]
8. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas.
Tamayo L; Ortiz DM; Orozco-Covarrubias L; Durán-McKinster C; Mora MA; Avila E; Teixeira F; Ruiz-Maldonado R
Arch Dermatol; 1997 Dec; 133(12):1567-71. PubMed ID: 9420543
[TBL] [Abstract][Full Text] [Related]
9. The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids.
Blei F; Isakoff M; Deb G
Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):841-4. PubMed ID: 9260550
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of severe cervicofacial hemangioma with interferon alpha-2b].
Mortureux P; Pedespan JM; Greselle JF; Devars F; Maleville J; Taïeb A
Arch Pediatr; 1995 Mar; 2(3):237-40. PubMed ID: 7742908
[TBL] [Abstract][Full Text] [Related]
11. The use of interferon alfa-2a for life-threatening hemangiomas.
MacArthur CJ; Senders CW; Katz J
Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):690-3. PubMed ID: 7772325
[TBL] [Abstract][Full Text] [Related]
12. Management of parotid hemangioma in 100 children.
Greene AK; Rogers GF; Mulliken JB
Plast Reconstr Surg; 2004 Jan; 113(1):53-60. PubMed ID: 14707622
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants].
Grimal I; Duveau E; Enjolras O; Verret JL; Giniès JL
Arch Pediatr; 2000 Feb; 7(2):163-7. PubMed ID: 10701062
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.
Ricketts RR; Hatley RM; Corden BJ; Sabio H; Howell CG
Ann Surg; 1994 Jun; 219(6):605-12; discussion 612-4. PubMed ID: 8203969
[TBL] [Abstract][Full Text] [Related]
15. [Interferon alpha and infantile orbital hemangioma].
Damas Mateache B; Menéndez Suso JJ; Abelairas Gómez JM; Albajara Velasco L; Peralta Calvo J; Verdú Sánchez C; Royo Orejas A
Arch Soc Esp Oftalmol; 2003 Nov; 78(11):623-9. PubMed ID: 14648369
[TBL] [Abstract][Full Text] [Related]
16. Multimodal management of diffuse neonatal hemangiomatosis.
Stratte EG; Tope WD; Johnson CL; Swanson NA
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):337-42. PubMed ID: 8655722
[TBL] [Abstract][Full Text] [Related]
17. [Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation].
Zhang L; Lin XX; Qi ZL; Dong JS; Zou LJ; Dai CC; Li W; Wang W
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):186-8. PubMed ID: 16635349
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha therapy for multiple hemangiomas associated with coarctation of the aorta.
Hijii T; Fukushige J; Tasaki K; Ueda K
Heart Vessels; 1996; 11(4):211-4. PubMed ID: 9119811
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma.
Sarkar M; Mulliken JB; Kozakewich HP; Robertson RL; Burrows PE
Plast Reconstr Surg; 1997 Nov; 100(6):1377-86. PubMed ID: 9385948
[TBL] [Abstract][Full Text] [Related]
20. Regression of infancy hemangiomas with recombinant IFN-alpha 2b.
Garmendía G; Miranda N; Borroso S; Longchong M; Martínez E; Ferrero J; Porrero P; López-Saura P
J Interferon Cytokine Res; 2001 Jan; 21(1):31-8. PubMed ID: 11177578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
